Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening. - Wikidata - awgldk - TriplyDB

Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening.

Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening.

http://www.wikidata.org/entity/Q41929558

about

Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders From tissue mechanics to transcription factors.Relationship of and cross-talk between physical and biologic properties of the glomerulus Macrophage motility is driven by frontal-towing with a force magnitude dependent on substrate stiffness C/EBP-Homologous Protein (CHOP) in Vascular Smooth Muscle Cells Regulates Their Proliferation in Aortic Explants and Atherosclerotic Lesions A FAK-Cas-Rac-lamellipodin signaling module transduces extracellular matrix stiffness into mechanosensitive cell cycling.Compression stiffening of brain and its effect on mechanosensing by glioma cells Application of multiple levels of fluid shear stress to endothelial cells plated on polyacrylamide gels.The arterial microenvironment: the where and why of atherosclerosis.Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review Age-related vascular stiffening: causes and consequences.Apolipoprotein E3 Inhibits Rho to Regulate the Mechanosensitive Expression of Cox2 In Vivo Antioxidant and Hypolipidemic Effects of Fermented Mung Bean on Hypercholesterolemic Mice.The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis.Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy.miR-181b regulates vascular stiffness age dependently in part by regulating TGF-β signaling.Matrix metalloproteinase-12 is an essential mediator of acute and chronic arterial stiffening A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions Stiff substrates enhance monocytic cell capture through E-selectin but not P-selectin Apolipoprotein E-mediated cell cycle arrest linked to p27 and the Cox2-dependent repression of miR221/222 Tissue mechanics and fibrosis.Matrix stiffness promotes cartilage endplate chondrocyte calcification in disc degeneration via miR-20a targeting ANKH expression.Liver-specific overexpression of LPCAT3 reduces postprandial hyperglycemia and improves lipoprotein metabolic profile in mice.Frail HDLs and stiff arteries in type 2 diabetes in juveniles.The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness.Low extracellular lysyl oxidase expression is associated with poor prognosis in patients with prostate cancer.Augmentation of integrin-mediated mechanotransduction by hyaluronic acid.Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice.Integrins in mechanotransduction Actin dynamics, architecture, and mechanics in cell motility.The role of apolipoprotein E in neurodegeneration and cardiovascular disease.Force Matters: Biomechanical Regulation of Cell Invasion and Migration in Disease.Biomechanical relationships between the corneal endothelium and Descemet's membrane.MicroRNA regulation of extracellular matrix components in the process of atherosclerotic plaque destabilization.Gap junction-mediated regulation of endothelial cellular stiffness Membrane-Tethered Metalloproteinase Expressed by Vascular Smooth Muscle Cells Limits the Progression of Proliferative Atherosclerotic Lesions.The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice.Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit.

P2860

Q26753129-46FC2D5B-3474-4C15-A46F-BF6577C00F84 Q26866255-A050AE84-C48A-426B-907F-2997C214F944 Q28083461-5CA92952-3469-41A1-ACEC-3433A5934024 Q28821772-51B7D7EF-5208-4A03-89EA-8D96F3F33DB4 Q30359005-2D6EF2EC-5E5A-48C4-988F-BC15A23CB986 Q30407809-978E93E2-7894-42BE-89B5-CB2091CD7CC7 Q30634187-D002EAD0-A4DD-495C-8181-39AAB422AA81 Q30657565-D01A7C06-03DB-4C7F-920B-3F32066A0B8A Q33619657-8088E8AE-9055-4DD9-80AE-3EBB9492DB36 Q34238630-8214A403-F2D2-4050-A092-46259B45C894 Q35409645-861FFEA1-7F6F-4FE3-AD30-CFB8FAFDE947 Q35661903-24BD72E7-02FC-41BA-95B0-E24B6CB8715B Q35667976-D6B9C6BF-AD11-4C82-A4B1-60FCD589009C Q35687138-D6E98A12-6722-4F63-8F36-2D2FBEDA0642 Q35762924-4428A84E-782C-4521-981E-A1093DBF4D19 Q36059910-06FFF2BE-3F93-45D6-8070-3790EEF34426 Q36180039-5347A0C8-7590-4CDA-898C-CB6B9B018C04 Q36316512-B5B2A724-705D-4087-9F52-66FE5124BA2C Q36320961-359C268E-3338-4B49-8198-38E86B091737 Q36370996-51F47F45-8F2E-45CB-99C9-C34CB45CD748 Q36502506-BAB8C517-A303-4A74-ACC1-5C52DF8EE86B Q36800668-AF2A0421-2691-49DC-AA8D-C64ABB4C6AE4 Q36809075-CA16567D-3E45-473A-A831-B2CE8158D974 Q36864767-8B555A97-0EEE-4899-B68F-A0D7EC68F12E Q36865070-623A92DA-0C9C-4147-997B-3B9776B96CBB Q37030996-B08B5A9E-D8C5-436D-AD3E-89EAC83AE1B5 Q37261536-154F3C7C-1A87-4E38-86D0-2F8A49E1634F Q37406845-75AB72D6-A420-495F-91A9-663AF3BA5B0B Q37595529-E9744EF5-68B0-49B5-B91D-DDE5F4714D21 Q37735500-89B3560C-6AEB-4E4B-820E-A7AEF0FE5292 Q38116705-C65F9CE0-6EE7-46C7-87B4-14E8AAEC2E82 Q38175137-654CCE94-B4C4-4718-AA86-7051AC79C505 Q38206263-2E59030A-34CD-4721-ACD1-CE43EABDDBBE Q38801418-A79BEC8F-DDD9-4EA7-9A74-690E55AB3F4B Q38957544-F4BA36DC-BE67-496B-8DEA-0B73B1C577CB Q39261257-AD31242D-AFDE-4370-9307-A2617A919040 Q41094488-6B01E0B3-4F30-46F4-8CD8-98E519F53509 Q41627049-7677E1A7-1B99-49CE-A9A0-07AAA849B2AE Q42137439-521397A0-EB06-4BFC-A45C-EDB1D6F80FB8 Q42201432-4FBC5675-FE8E-45D1-AF4F-97DEB92E6C8A

P2860

Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening.

http://www.wikidata.org/entity/Q41929558

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Cardiovascular protection by A ...... ssion and arterial stiffening.

@en

type

label

Cardiovascular protection by A ...... ssion and arterial stiffening.

@en

prefLabel

Cardiovascular protection by A ...... ssion and arterial stiffening.

@en

P1433

Q41929558-626288B3-71AE-4D08-9664-7753A7122EA3

P1476

Q41929558-66DCF220-923E-4D54-83F1-0340359C363F

P2093

Q41929558-09A043C4-055D-47B9-A899-B65B876ECB4C

Q41929558-0B808D1D-5DF5-400F-9301-0069F9E4B398

Q41929558-12307115-BB58-4BF5-8751-FF6BFBA8F0EA

Q41929558-3D1B5E94-15B2-4A06-BB3D-A2FA1C44BC40

Q41929558-4E476D96-884E-49DD-8EE0-AFDBD618D494

Q41929558-65DF2A1B-B0C4-49FF-B23E-1FC0082D354E

Q41929558-8EFA4F20-AB52-4879-BD43-966DF6CCF664

Q41929558-910D4364-3696-41DC-BD8C-2223161EB011

Q41929558-B487DC47-512B-4A43-992C-4DE5A4A8FE4C

Q41929558-CEDCFD77-8A84-4D11-A77E-BCC7C93C7F1E

P2860

Q41929558-02EF6F8E-B014-4084-81B5-85B4CEC22089

Q41929558-04E1199F-5DE5-4EB3-8A8C-62F1308AE04A

Q41929558-0659645B-39BC-4D6D-8A50-B0AA9D29E798

Q41929558-06C362A1-8DF0-4402-9169-7BCEADDDD979

Q41929558-0B53FD19-5454-4F33-A801-FCAD2DB2284C

Q41929558-10862C7D-DE38-4355-AAD9-89A9FD554AB9

Q41929558-162A578E-DCE1-4DD2-86A2-2F8AB7F13703

Q41929558-18B61765-F632-4A6F-BE6E-881B3A164C1A

Q41929558-19F0EA84-490F-4E92-AFF9-F39FFA901F86

Q41929558-23C0BBAB-3C3D-40CF-8846-D1C1C3B521B5

P304

Q41929558-322B9236-633A-4371-A0A6-6B2F1CF6E65F

P31

Q41929558-36109819-6B7A-48FD-A256-C430797F2B4F

P356

Q41929558-0725EB88-7659-42C4-97CB-53A73F16CAED

P433

Q41929558-3C85C2F3-B618-4F63-800B-028F2E52F8AC

P478

Q41929558-E4D28D4C-B84C-47CD-9385-D92F806382B6

P50

Q41929558-ED87EB0A-A1F2-447A-BE36-7A74B9D8BC91

P577

Q41929558-1C1F4C46-D592-40AF-A087-130C43C1D11D

P5875

Q41929558-78C131B3-328F-4387-8907-56C036048AC4

P698

Q41929558-DB664A04-B882-4777-B83F-601FD5ABF487

P932

Q41929558-8484F7B4-1DAC-4749-8E23-E756DF65DBEC

P356

J.CELREP.2012.09.018

P1433

P1476

Cardiovascular protection by A ...... ssion and arterial stiffening.

@en

P2093

Daniel J Rader

http://www.w3.org/2001/XMLSchema#string

Devashish Kothapalli

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Hawthorne

http://www.w3.org/2001/XMLSchema#string

Ellen Puré

http://www.w3.org/2001/XMLSchema#string

Fitzroy J Byfield

http://www.w3.org/2001/XMLSchema#string

James Monslow

http://www.w3.org/2001/XMLSchema#string

Paola Castagnino

http://www.w3.org/2001/XMLSchema#string

Paul A Janmey

http://www.w3.org/2001/XMLSchema#string

Richard K Assoian

http://www.w3.org/2001/XMLSchema#string

Shilpa Rao

http://www.w3.org/2001/XMLSchema#string

P2860

miR-145 and miR-143 regulate smooth muscle cell fate and plasticity

Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase

Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression

Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators

Matrix crosslinking forces tumor progression by enhancing integrin signaling

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury

From cholesterol transport to signal transduction: low density lipoprotein receptor, very low density lipoprotein receptor, and apolipoprotein E receptor-2

Lysyl oxidases: a novel multifunctional amine oxidase family

Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell

Transforming growth factor beta in tissue fibrosis

P304

1259-1271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELREP.2012.09.018

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Michael C. Phillips

P577

2012-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232702084

http://www.w3.org/2001/XMLSchema#string

P698

23103162

http://www.w3.org/2001/XMLSchema#string

P932

3535179

http://www.w3.org/2001/XMLSchema#string